✦ LIBER ✦

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

✍ Scribed by Vappu Rantalaiho; Markku Korpela; Pekka Hannonen; Hannu Kautiainen; Salme Järvenpää; Marjatta Leirisalo-Repo; Markku Hakala; Kari Puolakka; Heikki Julkunen; Riitta Luosujärvi; Timo Möttönen; FIN-RACo Trial Group

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 156 KB
Volume: 60
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.24447

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interleukin-6 receptor inhibition with t

Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: The tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study

✍ Mark C. Genovese; James D. McKay; Evgeny L. Nasonov; Eduardo F. Mysler; Nilzio A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Impact of initial aggressive drug treatm

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: A five-year randomized followup trial

✍ Kari Puolakka; Hannu Kautiainen; Timo Möttönen; Pekka Hannonen; Markku Korpela; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Abstract ## Objective To compare the efficacy of therapy with a combination of disease‐modifying antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work disability in patients with early rheumatoid arthritis (RA). ## Methods In the Finnish Rheumatoid Arthriti